Shree Ganesh Remedies Ltd.

As of June 30, 2026, Shree Ganesh Remedies Ltd. has 12.84M shares outstanding.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 5.31M in revenue per employee across its workforce of 186.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Shree Ganesh Remedies Ltd. recorded 55.09M in income tax expense. That works out to an effective tax rate of 26.30, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 209.48M, leaving 154.39M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Shree Ganesh Remedies Ltd. generated 989.78M in revenue and converted that into 154.39M in net income, yielding earnings per share of 12.02. EBITDA reached 310.72M, while operating income came in at 205.78M.

Over the twelve months ended June 30, 2026, Shree Ganesh Remedies Ltd. posted a gross margin of 64.40, reflecting its pricing power and cost economics. The operating margin of 20.79 and net profit margin of 15.60 provide insight into operational efficiency.

Shree Ganesh Remedies Ltd.'s most recent stock split took place on February 3, 2023.